Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Aging Knowl. Environ., 8 February 2006
Vol. 2006, Issue 5, p. pe5
[DOI: 10.1126/sageke.2006.5.pe5]

PERSPECTIVES

When Good Cdk5 Turns Bad

Qing Guo

The author is in the Department of Physiology at The University of Oklahoma Health Sciences Center, College of Medicine, Oklahoma City, OK 73104. E-mail: qing-guo{at}ouhsc.edu

http://sageke.sciencemag.org/cgi/content/full/2006/5/pe5

Key Words: Alzheimer's disease • cyclin-dependent kinase 5 • p25 • amyloid beta peptide • tau

Abstract: The cyclin-dependent kinase-5 (Cdk5) is critical to normal mammalian development and has been implicated in synaptic plasticity, learning, and memory in the adult brain. But Cdk-5 activity has also been linked to neurodegenerative diseases. Could a single protein have opposing effects? A new study shows that production of a neuronal protein capable of regulating Cdk-5 activity can turn Cdk-5 from "good" to "bad." The findings may have implications for the development and treatment of conditions like Alzheimer's disease.

Citation: Q. Guo, When Good Cdk5 Turns Bad. Sci. Aging Knowl. Environ. 2006 (5), pe5 (2006).

Read the Full Text




THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
L. Zhang, W. Liu, K. K. Szumlinski, and J. Lew (2012)
PNAS 109, 20041-20046
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science of Aging Knowledge Environment. ISSN 1539-6150